[Attitude of the adult patient with atopic dermatitis to the disease and its treatment: the ACTIDA Study].
OBJECTIVE
To determine the attitude of adult patients with atopic dermatitis (AD) to their disease and its treatment.


METHODS
A multicenter, cross-sectional study was performed in patients with at least 2 outbreaks of AD in the previous year.


RESULTS
Two hundred twenty-seven dermatologists recruited 1441 analyzable patients, the majority women, with a mean of 3.6 outbreaks per year. Most of the patients (97.2%) indicated that they always or sometimes requested medical evaluation of a new outbreak. In the most recent outbreak, 72.2% had used combined therapy, regardless of the severity of the episode; 2-drug combinations were the most common. The majority of dermatologists prescribed combined therapy, most commonly a 2-drug combination for mild or minimal disease, and 3 or more drugs for moderate to very severe outbreaks.


CONCLUSIONS
Treatments used by patients for an outbreak of AD are similar to those prescribed by dermatologists in recent outbreaks.
Betlloch
I
I
Servicio de Dermatología, Hospital General de Alicante, Alicante, Spain.
Izu
R
R
Lleonart
M
M
Ferrer
M
M
Ferrando
J
J
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001294:Attitude to Health; D003430:Cross-Sectional Studies; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000523:psychology*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004358:Drug Therapy / Q000523:psychology; D004359:Drug Therapy, Combination; D005260:Female; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009819:Office Visits / Q000706:statistics & numerical data; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D010361:Patients / Q000523:psychology*; D011788:Quality of Life; D013030:Spain; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D006633:Histamine Antagonists; D007166:Immunosuppressive Agents